Df Dent & CO Inc Illumina, Inc. Transaction History

Df Dent & CO Inc

$7.62 Billion
Q3 2024

A detailed history of Df Dent & CO Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Df Dent & CO Inc holds 121,815 shares of ILMN stock, worth $16.3 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

121,815

Previous 443,725 72.55%

Holding current value

$16.3 Million

Previous $46.3 Million 65.71%

% of portfolio

0.21%

Previous 0.65%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$105.28 - $135.9 $33.9 Million - $43.7 Million	-321,910 Reduced 72.55%	121,815 $15.9 Million
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $2.66 Million - $3.52 Million	-26,323 Reduced 5.6%	443,725 $46.3 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $14.6 Million - $16.8 Million	-114,231 Reduced 19.55%	470,048 $64.5 Million
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $18.7 Million - $28.8 Million	-201,726 Reduced 25.66%	584,279 $81.4 Million
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $5.06 Million - $6.42 Million	-27,597 Reduced 3.39%	786,005 $147 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $85,250 - $102,322	440 Added 0.05%	813,602 $189 Million
Q4 2022 Feb 15, 2023	BUY	$187.24 - $242.74 $8.48 Million - $11 Million	45,304 Added 5.9%	813,162 $164 Million
Q3 2022 Nov 14, 2022	SELL	$177.23 - $227.44 $1.49 Million - $1.91 Million	-8,410 Reduced 1.08%	767,858 $147 Million
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $2.49 Million - $5.04 Million	-13,704 Reduced 1.73%	776,268 $143 Million
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $2.8 Million - $3.91 Million	9,226 Added 1.18%	789,972 $276 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $30.5 Million - $37.1 Million	87,849 Added 12.68%	780,746 $297 Million
Q3 2021 Nov 15, 2021	SELL	$405.61 - $524.84 $3.16 Million - $4.09 Million	-7,796 Reduced 1.11%	692,897 $281 Million
Q2 2021 Aug 16, 2021	BUY	$372.84 - $481.5 $1.45 Million - $1.87 Million	3,886 Added 0.56%	700,693 $332 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $1.27 Million - $1.78 Million	3,526 Added 0.51%	696,807 $268 Million
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $5.69 Million - $7.22 Million	19,450 Added 2.89%	693,281 $257 Million
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $9.64 Million - $14.4 Million	35,920 Added 5.63%	673,831 $208 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $1.72 Million - $2.51 Million	-6,726 Reduced 1.04%	637,911 $236 Million
Q1 2020 May 15, 2020	BUY	$209.2 - $335.53 $19.2 Million - $30.9 Million	91,974 Added 16.64%	644,637 $176 Million
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $1.91 Million - $2.22 Million	6,618 Added 1.21%	552,663 $183 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $23.8 Million - $33.7 Million	89,079 Added 19.49%	546,045 $166 Million
Q2 2019 Aug 15, 2019	BUY	$300.59 - $368.15 $11.1 Million - $13.6 Million	37,012 Added 8.81%	456,966 $168 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $5.08 Million - $5.99 Million	18,648 Added 4.65%	419,954 $130 Million
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $23.2 Million - $31.2 Million	-85,181 Reduced 17.51%	401,306 $120 Million
Q3 2018 Nov 15, 2018	SELL	$279.04 - $367.06 $7.14 Million - $9.39 Million	-25,590 Reduced 5.0%	486,487 $179 Million
Q2 2018 Aug 15, 2018	BUY	$228.17 - $292.07 $2.51 Million - $3.22 Million	11,012 Added 2.2%	512,077 $143 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $29,545 - $35,801	-141 Reduced 0.03%	501,065 $118 Million
Q4 2017 Feb 15, 2018	BUY	$202.23 - $230.03 $2.97 Million - $3.38 Million	14,676 Added 3.02%	501,206 $110 Million
Q3 2017 Nov 15, 2017	BUY	$172.3 - $213.93 $83.8 Million - $104 Million	486,530	486,530 $96.9 Million

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account